Effect of an efflux pump inhibitor on the MIC of nalidixic acid for Acinetobacter baumannii and Stenotrophomonas maltophilia clinical isolates.
Ribera
Anna
A
Ruiz
Joaquim
J
Jiminez de Anta
M Teresa
MT
Vila
Jordi
J
D000150:Acinetobacter / Q000187:drug effects* / Q000378:metabolism; D000890:Anti-Infective Agents / Q000494:pharmacology*; D002939:Ciprofloxacin / Q000494:pharmacology; D004151:Dipeptides / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid / Q000494:pharmacology*; D012110:Reserpine / Q000494:pharmacology
D000890:Anti-Infective Agents; D004151:Dipeptides; C419365:phenylalanine arginine beta-naphthylamide; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D012110:Reserpine